Using an mRNA versus DNA test in the English cervical screening programme can save £15m annually and reduce unnecessary testing
The results of our economic evaluation comparing the use of mRNA and DNA assays in screening for cervical cancer in England were published in BMJ Open and are now available online. Results show large cost savings from avoiding unnecessary testing and follow-up, which can benefit women and healthcare services.
Improving patient care with rapid point of care tests
Dr Elisabeth Adams, Managing Director of Aquarius Population Health, presented on opportunities for rapid tests in influenza and HPV at international conferences in June. This has been a busy week for the Aquarius Population Health team. We had two posters at the Society for Medical Decision Making in London (12-15th June), which Elisabeth presented. The Read More >
Rapid on-demand testing of HPV and cervical cancer prevention: IPV Conference in Lisbon
Aquarius Population Health will be presenting European screening programmes outcomes and opportunities for rapid HPV testing in the UK at the 2015 HPV conference in Lisbon. http://www.hpv2015.org